Healthcare Industry News: TLIF
News Release - October 11, 2006
Medtronic Announces Availability of Crescent Instrument Set
MEMPHIS, Tenn.--(HSMN NewsFeed)--Medtronic, Inc. (NYSE:MDT ) today announced the U.S. market availability of the Crescent(TM) Instrument Set for use in orthopedic surgeries. This set of precision inserting and tamping instruments, trialing instruments and derotation and extraction instruments may be used by spine surgeons during construct insertion when performing a transforaminal lumbar interbody fusion (TLIF) and other procedures."The Crescent Instrument Set gives me the next generation of interbody instruments when I perform a TLIF or other spinal procedures. The instruments are streamlined and easier to use than earlier instrument sets and can help me complete my cases more quickly by reducing the time my patients spend in the operating room," said George Frey, M.D., of the Colorado Comprehensive Spine Institute in Englewood, Colo.
Among other features, the Crescent Instrument Set offers:
- Bullet-nose shaped trial and distractors that allows for easy insertion.
- A ball tip inserter for easy inserting, tamping, and final positioning.
- Straight and 15 degree offset inserter attachment options.
- Consistent 10mm anterior-posterior width trials for all construct lengths.
- Minimal Access Spinal Technologies (MAST(TM)) friendly instruments.
- Derotation tools to reposition an over-rotated surgical construct.
- Extraction tools to safely remove a surgical construct.
When used in a minimally invasive procedure, the Crescent Instrument Set could benefit patients by potentially reducing blood loss during surgery and potentially allowing for quicker recovery times.
"The Crescent Instrument Set gives me an easy insertion of constructs without the need for dural or neural retraction," added James D. Schwender, M.D., of the Twin City Spine Center in Minneapolis.
About the Spinal Business at Medtronic
Medtronic's spinal business, based in Memphis, Tenn., is the global leader in today's spine market and is committed to advancing the treatment of spinal conditions. Medtronic's spinal business collaborates with world-renowned surgeons, researchers and innovative partners to offer state-of-the-art products and technologies for neurological, orthopedic and spinal conditions. Medtronic is committed to developing affordable, minimally invasive procedures that provide lifestyle friendly surgical therapies. More information about the company and its spinal treatments can be found at www.medtronicspinal.com and its patient-education Web sites, www.back.com, www.iscoliosis.com, www.maturespine.com and www.necksurgery.com.
About Medtronic
Medtronic, Inc. (www.medtronic.com), headquartered in Minneapolis, is the global leader in medical technology - alleviating pain, restoring health, and extending life for millions of people around the world.
Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's Annual Report on Form 10-K for the year ended April 28, 2006. Actual results may differ materially from anticipated results.
The Crescent (TM) Instrument Set incorporates technology developed by Gary K. Michelson, M.D.
Source: Medtronic
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
Related News Items
Medtronic Achieves CE Mark Approval for BrainSense Adaptive Deep Brain Stimulation and Electrode Identifier, a Groundbreaking Advance In Personalized, Sensing-Enabled Care for People with Parkinson's Through Innovative Brain-Computer Interface TechnologyMedtronic Receives FDA Clearance for New InPen(TM) App, Paving the Way for its Smart MDI System Launch with Simplera(TM) CGM
Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life
